Virax Biolabs Group Ltd

Virax Biolabs Group Ltd. is a holding company. It engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Earnings data Q2 2024

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Mobile Global Esports Inc

Sobr Safe Inc

Which penny stocks are on your watchlist today? The post Hot Penny Stocks to Buy?

Hot Penny Stocks to Buy? 3 to Watch as September Ends

Trxade Group

High volume penny stocks for your September watch list. The post 3 High Volume Penny Stocks To Watch Before FOMC Meeting appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 High Volume Penny Stocks To Watch Before FOMC Meeting

Source: Gorodenkoff / Shutterstock.com No question about it — traders are taking notice of Virax Biolabs (NASDAQ: VRAX ) today. That's because VRAX stock is soaring 40% this morning after Virax revealed a rapid test kit specially designed to detect monkeypox.

Why Is Virax Biolabs (VRAX) Stock Up 40% Today?

LONDON , Sept. 12, 2022 /PRNewswire/ -- Virax Biolabs ("Virax" or the "Company") (NASDAQ: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today announced that Chairman of the Board and Chief Executive Officer, James Foster is presenting at H.C.

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

LONDON , Sept. 6, 2022 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today announced that Virax's Chairman of the Board of Directors and Chief Executive Officer, Mr.

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Bright Green Corp

Volcon

Penny stocks to buy for under $5 but are they worth the risk? The post 3 Hot Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Hot Penny Stocks To Buy For Under $5 Right Now

Denison Mines

New Age Beverages

Which penny stocks are you watching today? The post Trending Penny Stocks to Buy in September?

Trending Penny Stocks to Buy in September? 3 For Your List

LONDON , Aug. 16, 2022 /PRNewswire/ -- Virax Biolabs ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today announced that Chairman of the Board and Chief Executive Officer, James Foster will ring the Nasdaq Stock Market closing bell on Thursday, August 18, 2022. This comes after Virax began listing its common shares on the Nasdaq Capital Market on July 21, 2022.

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

The stock price of Virax Biolabs (VRAX) increased by 119.44% today. This is why.

Virax Biolabs (VRAX) Stock: Why It Skyrocketed 119.44% Today

Virax Biolabs (NASDAQ: VRAX ), a specialist in diagnostic tests, veritably captured the market news cycle today, with its shares skyrocketing 120% before giving up some ground in the afternoon session. Still, VRAX stock is about double from its prior closing price.

VRAX Stock Alert: Why Is Virax Biolabs Up 120% Today?

Geovax Labs

SIGA Technologies

Monkeypox stocks are rallying amid worries about a shortage of vaccines for the illness in the U.S. Additionally, in recent days, New York state, New York City and San Francisco have issued emergency orders related to monkeypox. Several related names rallied in pre-market trading today and are still up since the market opened this morning.

Monkeypox Stocks GOVX, VRAX, SIGA Rocket on Vaccine Shortage Fears

The stock had a wild trading day with an initial upswing, followed by a strong downtrend.

Why Virax Biolabs Stock Plummeted 74% On Friday

Kits Available in July for Distribution Kits Available in July for Distribution

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

Bausch Health Companies Inc

Bausch + Lomb Corp

Medtronic

Meihua International Medical Technologies Co

Tenon Medical Inc

At least one group is bullish about the outlook for the medtech industry: venture capitalists.

Investors May Want to Follow Progress of VC-Backed Medtechs

London, United Kingdom, July 21, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today announced it has completed its initial public offering (IPO), and the Company's shares began trading today on the Nasdaq Capital Market under the ticker symbol "VRAX."

Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

London, United Kingdom, July 20, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today announced the pricing of its firm commitment initial public offering of 1,350,000 ordinary shares at a public offering price of $5.00 per share, for total gross proceeds of $6.75 million, before deducting underwriting discounts, commissions, and other related expenses. The shares are scheduled to begin trading on the Nasdaq Capital Market tomorrow, July 21, 2022, under the ticker symbol "VRAX." The offering is expected to close on or about July 25, 2022, subject to customary closing conditions.

News for Virax Biolabs Group Ltd Stock (VRAX)